Kahl, Klaus-Henning http://orcid.org/0000-0002-0545-1367
Balagiannis, Nikolaos
Höck, Michael
Schill, Sabine
Roushan, Zoha
Shiban, Ehab
Müller, Heiko
Grossert, Ute
Konietzko, Ina
Sommer, Björn
Maurer, Christoph J.
Berlis, Ansgar
Heidecke, Volkmar
Janzen, Tilman
Stüben, Georg
Funding for this research was provided by:
Universitätsklinikum Augsburg
Article History
Received: 24 March 2021
Accepted: 18 July 2021
First Online: 20 August 2021
Declarations
:
: K.-H. Kahl has received speaker honoraria and travel grants from ELEKTA AB, Varian Medical Systems, Carl Zeiss Meditec AG, AstraZeneca, Bristol Myers Squibb, MSD, Merck, and Medical Intelligence Medizintechnik. N. Balagiannis, M. Höck, S. Schill, Z. Roushan, E. Shiban, H. Müller, U. Grossert, I. Konietzko, B. Sommer, C.J. Maurer, A. Berlis, V. Heidecke, T. Janzen, and G. Stüben declare that they have no competing interests.
: This research study was conducted retrospectively from data obtained for clinical purposes. It was approved by the local review board (UKA). It consists of experts of all medical disciplines involved and conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000). <i>Consent to participate</i>: Patients gave informed consent to the treatment and the data analysis. The statistical analysis was performed using anonymous clinical data. <i>Consent for publication</i>: Patients also gave informed consent to publish their data.